Qianjinweijing Decoction Protects Against Fine Particulate Matter Exposure-mediated Lung Function Disorder.
Qianjinweijing Decoction Protects Against Fine Particulate Matter Exposure-mediated Lung Function Disorder.
复制标题
DOI:
10.3389/fphar.2022.873055
复制
发表时间:
2022
影响因子:
5.6
通讯作者:
Liu, Cuiqing
中科院分区:
文献类型:
--
作者:
Chen, Rucheng;Zhang, Jinna;Pang, Yaxian;Liu, Qingping;Peng, Jing;Lin, Xiujuan;Cao, Lingyong;Gu, Weijia;Zhang, Lu;Li, Ran;Sun, Qinghua;Zhang, Rong;Liu, Cuiqing
关键词:
Fine particulate matter (PM2.5) is well known to impair lung function. Strategies protecting against PM2.5-exerted lung dysfunction have been less investigated. Qianjinweijing decoction (QJWJ), a decoction of a herbal medicine of natural origin, has been used to treat lung disorders as it inhibits oxidation and inflammation. However, no clinical trial has yet evaluated the role of QJWJ in PM2.5-induced lung dysfunction. Therefore, we conducted a randomized, double-blind, placebo-controlled trial to assess whether QJWJ provided lung benefits against the adverse effects of PM2.5 exposure among adults. Eligible participants (n = 65) were recruited and randomized to receive QJWJ decoction (n = 32) or placebo (n = 33) for 4 weeks. The restrictive ventilatory defect (RVD), lung function parameters, and induced sputum were analyzed. The PM2.5 exposure concentration was significantly associated with the vital capacity (VC), peak expiratory flow (PEF), and forced expiratory flow at 75% of the forced vital capacity (FEF75). The negative associations between PM2.5 and the lung function parameters were eliminated in response to the QJWJ intervention. Additionally, the percentage of RVD (P = 0.018) and the proportion of eosinophils (Eo%) in induced sputum (P = 0.014) in the QJWJ group was significantly lower than that in the placebo group. This study demonstrated that QJWJ could alleviated PM2.5-induced lung dysfunction and could be a potential treatment for air pollution-related chronic respiratory disease.
登录
查看更多内容
影响因子:
7.3
作者:
Falcon-Rodriguez CI;Osornio-Vargas AR;Sada-Ovalle I;Segura-Medina P
通讯作者:
Segura-Medina P
DOI:
10.1016/s0140-6736(18)32225-6
发表时间:
2018-11-10
期刊:
Lancet (London, England)
影响因子:
--
作者:
GBD 2017 Risk Factor Collaborators
通讯作者:
GBD 2017 Risk Factor Collaborators
影响因子:
24
作者:
Lin, Zhijing;Chen, Renjie;Kan, Haidong
通讯作者:
Kan, Haidong
影响因子:
8.3
作者:
Hwang, Bing-Fang;Chen, Ya-Hui;Lee, Yungling Leo
通讯作者:
Lee, Yungling Leo
影响因子:
5.4
作者:
Tasmin, Saira;Ng, Chris Fook Sheng;Watanabe, Chiho
通讯作者:
Watanabe, Chiho